Snowball will help you to track your portfolio, plan deposits to your brokerage account and support your passive income strategy with tools and community of investors
What sector does Merck & Co. Inc (6MK) operate in?
Merck & Co. Inc belongs to the Healthcare sector and operates in the Drug Manufacturers - General industry.
What is Merck & Co. Inc (6MK) current stock price?
As of the latest data, Merck & Co. Inc stock price is €70.60, with a previous close of €72.20. Merck & Co. Inc lost -€1.60 in the last trading session, representing a -2.22% loss.
What is Merck & Co. Inc (6MK) current market capitalization?
Merck & Co. Inc market cap is approximately 177.28 billion.
What is Merck & Co. Inc (6MK) Earnings Per Share (EPS)?
The trailing EPS is €5.99.
What is Merck & Co. Inc (6MK) Price-to-Earnings (P/E) ratio?
Merck & Co. Inc current P/E ratio is 11.79.
What is Merck & Co. Inc (6MK) EBITDA?
Merck & Co. Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 6.76 billion.
Does Merck & Co. Inc (6MK) pay dividends?
Yes. Merck & Co. Inc pays quarterly dividends with an annualized yield of 3.36% and an estimated annual payout of €2.77 per share.
When is the next ex-dividend date for Merck & Co. Inc (6MK)?
The next ex-dividend date is scheduled for September 16, 2025.
When is Merck & Co. Inc (6MK) next earnings report?
Merck & Co. Inc is expected to release its next earnings report on June 30, 2025.
What is Merck & Co. Inc (6MK) beta (volatility) score?
Merck & Co. Inc has a beta of 0.441, indicating lower volatility than the overall market.